Last reviewed · How we verify
tree 12 SQ-Bet
Tree 12 SQ-Bet is an allergen immunotherapy product that desensitizes patients to tree pollen allergens through gradual exposure.
Tree 12 SQ-Bet is an allergen immunotherapy product that desensitizes patients to tree pollen allergens through gradual exposure. Used for Allergic rhinitis and/or allergic asthma caused by tree pollen allergens.
At a glance
| Generic name | tree 12 SQ-Bet |
|---|---|
| Also known as | ITULATEK |
| Sponsor | Clinique Spécialisée en Allergies de la Capitale |
| Drug class | Allergen immunotherapy (sublingual tablet) |
| Target | Tree pollen allergens (IgE cross-linking epitopes) |
| Modality | Small molecule |
| Therapeutic area | Immunology / Allergy |
| Phase | FDA-approved |
Mechanism of action
This is a sublingual immunotherapy (SLIT) tablet containing standardized tree pollen allergen extract, likely from multiple tree species. It works by inducing immune tolerance through repeated sublingual administration, shifting the immune response from Th2-mediated allergic reactions toward Th1/Treg-mediated tolerance. The mechanism involves gradual upregulation of regulatory T cells and IL-10 production, reducing allergic symptoms upon natural allergen exposure.
Approved indications
- Allergic rhinitis and/or allergic asthma caused by tree pollen allergens
Common side effects
- Oral pruritus
- Throat irritation
- Ear pruritus
- Mild local swelling
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tree 12 SQ-Bet CI brief — competitive landscape report
- tree 12 SQ-Bet updates RSS · CI watch RSS
- Clinique Spécialisée en Allergies de la Capitale portfolio CI